FDA Inspection 1250221 — Penn State Health Lancaster Medical Center
The FDA completed an inspection of Penn State Health Lancaster Medical Center on Sep 16, 2024 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 16, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lancaster, PA (United States)